Pfizer Limited (PFIZER.NS)
NSE · INR · Healthcare · Drug Manufacturers - General
₹3,709.80 (+0.61%) as of
Key statistics
- Market cap
- 169.71B
- P/E (TTM)
- 23.09
- Forward P/E
- 18.13
- EPS (TTM)
- 160.70
- Dividend yield
- 2.03%
- 52-week range
- 3,589.00 – 5,346.00
- Beta
- 0.13
- Revenue (TTM)
- 25.7B
- Profit margin
- 28.61%
- Analyst target
- ₹6,008.50
- Volume
- 16.96k
About Pfizer Limited
Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers therapy area and products, such as vaccines, injectables and anti-infectives, inflammation and immunology, and internal medicine for cardiovascular care, oncology, respiratory, multivitamins and multimineral, neuroscience, women's health, gastroenterology, pain management, and nutrition, addressing. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Headquarters
- Mumbai, India
- Employees
- 1,244
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.